Analyst Reco. Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Real-time Estimate Cboe BZX Other stock markets 08:25:53 29/04/2024 pm IST			5-day change	1st Jan Change
9.08 ^USD	+0.44%		+0.78%	-2.15%

06/03	Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating	MT
21/02	Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating	06/03	MT
Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating	21/02	MT
Mizuho Trims Price Target on Pediatrix Medical to $9 From $10, Maintains Neutral Rating	21/02	MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $10 From $10.50, Keeps Hold Rating	21/02	MT
UBS Initiates Coverage on Pediatrix Medical Group With Neutral Rating, $9.50 Price Target	30/11	MT
Deutsche Bank Cuts Pediatrix Medical Price Target to $9 From $14, Maintains Sell Rating	03/11	MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $15 From $17, Maintains Hold Rating	09/23/09	MT
Deutsche Bank Adjusts Pediatrix Medical Price Target to $14 From $15.50, Maintains Sell Rating	03/23/03	MT
Credit Suisse Adjusts Price Target on Pediatrix Medical to $23 From $27, Maintains Outperform Rating	22/23/22	MT
Credit Suisse Adjusts Pediatrix Medical Group's Price Target to $27 From $28, Keeps Outperform Rating	05/22/05	MT
Mizuho Adjusts Price Target on Pediatrix Medical to $17 From $21, Maintains Neutral Rating	16/22/16	MT
SVB Leerink Adjusts Price Target on Pediatrix Medical to $16 From $20, Maintains Market Perform Rating	04/22/04	MT
Deutsche Bank Adjusts Pediatrix Medical Group Price Target to $14 From $16, Maintains Sell Rating	04/22/04	MT
Credit Suisse Lowers Pediatrix Medical Group's Price Target to $28 from $30 After Lower-than-Expected Q2 EBITDA, Keeps Outperform Rating	11/22/11	MT
BMO Capital Lowers Pediatrix Medical Group's Price Target to $23 From $25, Maintains Market Perform Rating	10/22/10	MT
S&P Raises Pediatrix Medical Group Rating To 'BB-' On Better Leverage, Stable Growth; Outlook Stable	13/22/13	MT
SVB Securities Adjusts Mednax's Price Target to $20 from $24, Keeps Market Perform Rating	12/22/12	MT
Deutsche Bank Adjusts Price Target on Mednax to $16 From $24, Maintains Sell Rating	10/22/10	MT
Credit Suisse Trims Mednax's PT to $30 from $31, Lowers 2022, 2023 Estimates as Q1 Underperformed Consensus on Ex-Pro Forma Basis; Maintains Outperform Rating	03/22/03	MT
Mizuho Adjusts Mednax's Price Target to $23 from $28, Keeps Neutral Rating	03/22/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Analyst Reco.

Filters